U.S. federal trademark · Serial No. 97033394 · Reg. No. 7021995
Development of platform technology, namely, immunotherapy pharmaceutical platforms for use in manufacturing therapeutics related to inflammaging, inflammatory diseases, age-related diseases and cancer; Medical and scientific research and development services in the field of protein therapeutics and immunotherapeutics; pharmaceutical product development; pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of age-related and inflammatory diseases and cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.